. Author manuscript; available in PMC: 2018 Apr 1.

Published in final edited form as: J Neurol Phys Ther. 2017 Apr;41(2):119–128. doi: 10.1097/NPT.0000000000000177

Table 3. AEX utilization for individuals with stroke by U.S. PTs.

Agree that AEX should be part of stroke rehab (n=482)	423 (87.8%)
Able to prescribe AEX for every individual with stroke for whom it is indicated (n=480)	346 (72.1%)
Perceive ≥ 1 barrier to routine AEX prescription for individuals with stroke (n=480)	402 (83.8%)
*Acute care (n=81)*
-Prescribe AEX for >0% of individuals with stroke	54 (66.7%)
-Prescribe AEX for >50% of individuals with stroke	20 (24.7%)
*Non-acute clinical practice settings (n=403)*
-Prescribe AEX for >0% of individuals with stroke	375 (93.1%)
-Prescribe AEX for >50% of individuals with stroke	247 (61.3%)

Values are n (%). Multiple survey questions. There were no significant differences among practice settings for the top 3 rows.